Growth Metrics

Ironwood Pharmaceuticals (IRWD) Change in Cash (2016 - 2026)

Ironwood Pharmaceuticals' Change in Cash history spans 16 years, with the latest figure at $75.0 million for Q4 2025.

  • On a quarterly basis, Change in Cash rose 21465.8% to $75.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $126.9 million, a 3629.82% increase, with the full-year FY2025 number at $126.9 million, up 3629.82% from a year prior.
  • Change in Cash hit $75.0 million in Q4 2025 for Ironwood Pharmaceuticals, up from $47.6 million in the prior quarter.
  • Over the last five years, Change in Cash for IRWD hit a ceiling of $84.1 million in Q1 2023 and a floor of -$565.5 million in Q2 2023.
  • Historically, Change in Cash has averaged -$7.5 million across 5 years, with a median of $24.7 million in 2024.
  • Biggest five-year swings in Change in Cash: plummeted 535.3% in 2023 and later surged 21465.8% in 2025.
  • Tracing IRWD's Change in Cash over 5 years: stood at $45.9 million in 2021, then surged by 78.87% to $82.0 million in 2022, then plummeted by 123.54% to -$19.3 million in 2023, then surged by 101.8% to $348000.0 in 2024, then surged by 21465.8% to $75.0 million in 2025.
  • Business Quant data shows Change in Cash for IRWD at $75.0 million in Q4 2025, $47.6 million in Q3 2025, and -$15.6 million in Q2 2025.